Serum IL-6 and CRP as prognostic factors in melanoma patients receiving single agent and combination checkpoint inhibition Meeting Abstract


Authors: Weber, J. S.; Tang, H.; Hippeli, L.; Qian, M.; Wind-Rotolo, M.; Larkin, J. M. G.; Wolchok, J. D.; Sznol, M.; Robert, C.; Woods, D. M.; Laino, A. S.; Hodi, F. S.
Abstract Title: Serum IL-6 and CRP as prognostic factors in melanoma patients receiving single agent and combination checkpoint inhibition
Meeting Title: 55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15 Suppl.
Meeting Dates: 2019 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-20
Start Page: 6s
Language: English
ACCESSION: WOS:000487345803485
DOI: 10.1200/JCO.2019.37.15_suppl.100
PROVIDER: wos
Notes: Meeting Abstract: 100 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok